$0.07 -0.01 (-7.43%)
11/27/2009 12:59 PM

La Jolla Pharmaceutical Company (LJPC)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to improving and preserving human life by developing innovative pharmaceutical products.

Results 1 - 14 of 14

Recs

1
Member Avatar gklein711 (25.26) Submitted: 1/1/2008 8:57:29 AM : Outperform Start Price: $3.89 LJPC Score: -76.10

Insiders bought all of new offering, but the stock went down from their buy-in pooint. It has now stabilized and should build from its' new bottom.

Recs

0
Member Avatar aaroger (26.05) Submitted: 7/20/2007 2:08:07 PM : Outperform Start Price: $4.31 LJPC Score: -73.23

5

Recs

0
Member Avatar Hazet808T5 (< 20) Submitted: 6/28/2007 4:12:34 PM : Outperform Start Price: $4.56 LJPC Score: -74.88

http://valueplays.blogspot.com/2007/06/this-weeks-insider-buys.html

Recs

0
Member Avatar lkuhnen (< 20) Submitted: 6/12/2007 8:34:33 AM : Outperform Start Price: $5.23 LJPC Score: -75.53

Second iterim results will come out early 2008. These results will be based on primary end points.

Recs

0
Member Avatar herbieenos (95.42) Submitted: 4/29/2007 4:12:51 AM : Outperform Start Price: $6.62 LJPC Score: -76.34

Prominent and patented in Europe and China for Lupis drug nearing announcement of stage 3 testing. Recent big money moved in at only $6 for sizable returns to come.

Recs

0
Member Avatar N0rMan17 (< 20) Submitted: 4/23/2007 1:50:01 AM : Outperform Start Price: $6.62 LJPC Score: -77.00

Alot of potencial to outperform the market.

Recs

0
Member Avatar olemt (21.90) Submitted: 4/10/2007 9:07:08 AM : Outperform Start Price: $5.79 LJPC Score: -81.57

Superbullish after very long and flat consolidation. I don't think this stock will stop until it reaches a m/c of 1 billion.

Recs

0
Member Avatar jazper292 (< 20) Submitted: 4/4/2007 5:24:35 PM : Outperform Start Price: $6.00 LJPC Score: -79.44

Trading markets 10

Recs

0
Member Avatar CycleFreak7 (< 20) Submitted: 3/23/2007 3:13:25 PM : Outperform Start Price: $7.24 LJPC Score: -79.74

EPS100Momentum said it all ...

http://caps.fool.com/Blogs/ViewPost.aspx?bpid=5601&t=01007468826027738866

Recs

0
Member Avatar golfman61291 (< 20) Submitted: 3/13/2007 1:27:19 PM : Underperform Start Price: $7.20 LJPC Score: +82.37

they suck

Recs

0
Member Avatar montgolearn (< 20) Submitted: 3/12/2007 7:22:21 PM : Outperform Start Price: $7.71 LJPC Score: -82.04

A good drug candidate for Lupus with nice phase 3 results.

Recs

1
Member Avatar aglas (< 20) Submitted: 3/11/2007 7:46:11 PM : Underperform Start Price: $5.90 LJPC Score: +81.62

A positive sounding press release about a product that failed to impress in the past sounds all too much like stock manipulation to take profit.

Recs

0
Member Avatar octopibingo (56.89) Submitted: 3/10/2007 1:17:01 PM : Underperform Start Price: $5.90 LJPC Score: +81.62

Way up on light results, way down on same.

Recs

3
Member Avatar dailylaw (< 20) Submitted: 3/8/2007 8:13:13 PM : Outperform Start Price: $4.18 LJPC Score: -80.60

Company has been developing its Lupis drug for many years. Failure of the first P3 trial was unexpected and FDA suggested/agreed to a further P3 trial. Preliminary results to the latest trial are very positive and the future looks bright.

Results 1 - 14 of 14

Featured Broker Partners